Macrophage Migration Inhibitory Factor (MIF) is a Key Player in Dry Eye Disease

CONCLUSION: MIF is a central positive mediator of the inflammatory process in experimental DED, thus, targeting MIF could be used as a novel therapy in ocular surface inflammatory pathologies.PMID:38127798 | DOI:10.1080/09273948.2023.2290624

Source: Ocular Immunology and Inflammation - December 21, 2023 Category: Allergy & Immunology Authors: Luis A Rivera Pablo E Hern ández Danielle T Vannan Jos é L Reyes Tonathiu Rodr íguez Ángel Sánchez-Barrera Marisol I Gonz ález Jos é Bustos Oscar A Ramos Imelda Ju árez Miriam Rodriguez-Sosa Alicia V ázquez Source Type: research